These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22507491)

  • 1. The developing clinical problem of chemotherapy-induced hepatic injury.
    Pilgrim CH; Thomson BN; Banting S; Phillips WA; Michael M
    ANZ J Surg; 2012; 82(1-2):23-9. PubMed ID: 22507491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.
    Khan AZ; Morris-Stiff G; Makuuchi M
    J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.
    Morris-Stiff G; Tan YM; Vauthey JN
    Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
    Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
    Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    Stevenson HL; Prats MM; Sasatomi E
    BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
    Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
    J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological features and severity of oxaliplatin-induced liver injury and clinical associations.
    Nalbantoglu IL; Tan BR; Linehan DC; Gao F; Brunt EM
    J Dig Dis; 2014 Oct; 15(10):553-60. PubMed ID: 25060628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
    Duwe G; Knitter S; Pesthy S; Beierle AS; Bahra M; Schmelzle M; Schmuck RB; Lohneis P; Raschzok N; Öllinger R; Sinn M; Struecker B; Sauer IM; Pratschke J; Andreou A
    Eur J Surg Oncol; 2017 Sep; 43(9):1668-1681. PubMed ID: 28599872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.
    Hebbar M; Pruvot FR; Romano O; Triboulet JP; de Gramont A
    Cancer Treat Rev; 2009 Dec; 35(8):668-75. PubMed ID: 19733977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases].
    Gómez-Ramírez J; Martín-Pérez E; Amat CG; Sanz IG; Bermejo E; Rodríguez A; Larrañaga E
    Cir Esp; 2010 Dec; 88(6):404-12. PubMed ID: 20971458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
    Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
    Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.
    Fernandez FG; Ritter J; Goodwin JW; Linehan DC; Hawkins WG; Strasberg SM
    J Am Coll Surg; 2005 Jun; 200(6):845-53. PubMed ID: 15922194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.
    Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P
    Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in neoadjuvant therapy for colorectal cancer with liver metastases.
    Pozzo C; Barone C; Kemeny NE
    Cancer Treat Rev; 2008 Jun; 34(4):293-301. PubMed ID: 18291590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal liver metastases.
    Tzeng CW; Aloia TA
    J Gastrointest Surg; 2013 Jan; 17(1):195-201; quiz p.201-2. PubMed ID: 23054896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved first-line chemotherapy: a better chance for surgery?
    Tejpar S; Van Cutsem E; Adam R
    Lancet Oncol; 2010 Jan; 11(1):4-5. PubMed ID: 19942480
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
    Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
    Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
    Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
    Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?
    Pinto Marques H; Barroso E; de Jong MC; Choti MA; Ribeiro V; Nobre AM; Carvalho C; Pawlik TM
    J Surg Oncol; 2012 May; 105(6):511-9. PubMed ID: 22065486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.